Certified by Founder Lodge 
                                        
                                        Character Biosciences
 
                                                 United States  -  San Francisco, CA 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $39,000,000
                                            0 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Our mission is to identify the genetic a
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| March, 27 ,2025 | Series B | $39,000,000 | |
| September, 19 ,2025 | Series B | Undisclosed Amount | 
                                                
 aMoon Fund
                                                                                
                                                                            
 KdT Ventures
                                                                                
 Catalio Capital Management
                                                                                
 S32
                                                                                
 Luma Group
                                                                                
 Bausch + Lomb
                                                                                
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                IORGANBIO |  $2,000,000  | (Oct 30, 2025)
                                                                        
                                Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025)
                            
                                                                        
                                Vesence |  $9,000,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                Reflectiz |  $22,000,000  | (Oct 30, 2025)